PathGen
Indonesian healthcare biotechnology firm PathGen raises funding from East Ventures, Royal Group Indonesia
PathGen Diagnostik Teknologi (PathGen), an Indonesia-based healthcare biotechnology startup, announced Friday that it has raised funding from venture capital firms East Ventures and Royal Group Indonesia.
April 19, 2024
Thunes Asia receives IPA to expand scope of MPI license from MAS
December 3, 2025
Temasek backs Black Forest Labs’ $300M Series B funding
December 3, 2025
Thunes Asia receives IPA to expand scope of MPI license from MAS
December 3, 2025
Temasek backs Black Forest Labs’ $300M Series B funding
December 3, 2025




